Treatment of human papillomavirus in childhood with imiquimod 5% cream
An Bras Dermatol. 2010 Jul-Aug;85(4):549-53.
doi: 10.1590/s0365-05962010000400020.
[Article in
English,
Portuguese]
Affiliation
- 1 Departamento de Dermatologia, Universidade de São Paulo, São Paulo, SP, Brasil. hebertbrandt@yahoo.com.br
Abstract
In children, lesions caused by the human papillomavirus (HPV) constitute a significant epidemiological issue and a therapeutic dilemma, particularly in the case of anogenital warts. The treatment of anogenital warts in children is a challenge, since standard treatments are generally painful and require the patient to be anesthetized. Imiquimod, a topical immune response modifier, constitutes an alternative therapeutic agent for the treatment of HPV. The present report describes four cases in which treatment with topically applied imiquimod 5% cream was implemented with successful results.
MeSH terms
-
Adjuvants, Immunologic / administration & dosage*
-
Administration, Topical
-
Aminoquinolines / administration & dosage*
-
Child, Preschool
-
Condylomata Acuminata / diagnosis
-
Condylomata Acuminata / drug therapy*
-
Condylomata Acuminata / etiology
-
Female
-
Humans
-
Imiquimod
-
Infant
-
Male
-
Treatment Outcome
Substances
-
Adjuvants, Immunologic
-
Aminoquinolines
-
Imiquimod